# Early Goal Directed Sedation on Microcirculation in Septic Shock

> **NCT02612363** · PHASE4 · UNKNOWN · sponsor: **Southeast University, China** · enrollment: 25 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Dexmedetomidine for sedation

## Key facts

- **NCT ID:** NCT02612363
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612363, "Early Goal Directed Sedation on Microcirculation in Septic Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02612363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*